Saw Palmetto and Saw Palmetto for Benign prostatic hyperplasia
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Saw Palmetto
The classic prostate supplement — large trials say mostly placebo, though some men report symptom relief.
Grade C1 graded outcomerevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Evidence brief
Saw Palmetto for Benign prostatic hyperplasia
Evidence grade C — Trial 8–12 weeks
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
No outcome has the same name in both entries. They may still overlap under different wording — read the two lists below.
Graded only in Saw Palmetto
- BPH urinary symptoms Small effectEvidence grade C
Graded only in Saw Palmetto for Benign prostatic hyperplasia
- Benign prostatic hyperplasia Unclear effectEvidence grade C
Conditions
Only in Saw Palmetto
- Benign prostatic hyperplasia May improveEvidence grade C
Only in Saw Palmetto for Benign prostatic hyperplasia
None.
What each entry says about the other
- Saw Palmetto for Benign prostatic hyperplasia’s entry · Goes with: Read the full Saw Palmetto monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.